atepeq/tico19 huggingface dataset:
about how long have these symptoms been going on?
Mallattooleen kun yeroo hammamiif mul’achaa jira?
and all chest pain should be treated this way especially with your age
Dhukkubbiin laphee hunduu kara kana yaalamuu qabu; keessumaa umuriikee waliin
and along with a fever
Ho’ina qaamaa waliin
and also needs to be checked your cholesterol blood pressure
Fi cholesterol kee ilaalamuu si barbaachisa
and are you having a fever now?
Amma ho’ina qaamaa qabdaa?
and are you having any of the following symptoms with your chest pain
Laphee dhukkubbiitti aanee kan dhufe mallattoolee kan biraa qabdaa?
and are you having a runny nose?
Furrii qal’aan funyaan keessaan si ba’aa?
and are you having this chest pain now?
Dhukkubbiin laphee kun amma sitti in dhaga’amaa?
and besides do you have difficulty breathing
Kana malees, dhibee hargansuu jabaa qabdaa?
and can you tell me what other symptoms are you having along with this?
Mallattoowwan gara biroo kana waliin qabaachaa jirtus natti himuu dandeessa.
and does this pain move from your chest?
Fi dhibee lapheekee gara biraatti ce’eeraa?
and drink lots of fluids
Fi waantota dhangalaa’aa baayy’isii dhugi
and how high has your fever been
Fi ho’inni qaamaaketii hagam ol ka’e
and i have a cough too
Akkasumas qufaa qaba
and i have a little cold and a cough
Kana malees, ani qorra xiqqoo fi qufaan qaba.
and i'm really having some bad chest pain today
Har’a dhukkubbii qomaa cimaatu natti dhaga’amaa jira.
and is this the right time for your hay fever
Kunimmoo ho’ina qaamakee sanaaf yeroo sirriidhaa?
and it get the chest pain
Ergasii laphee dhukkubbiin na jalqabe
and i think i have a little bit of a fever
ho’ina qaamaa xiqqoo nan qaba jedheen yaada.
and i want you to describe where the chest pain is
Fi ani dhukkubbiin laphee sun eessa akka ta’e akka ati naaf ibsitun barbaade
and she is sorta have the same symptoms
Isheenis mallattoolee kan warra kaanii wajjin wal-fakkaatutu irratti argame
and tell me what symptoms are you having now?
Fi mallattoolee amma sitti dhaga’amaa jiran natti himi?
and they're having some fevers as well
fi akkasumas isaan ho’ina qaamaa hamma ta’e qabu
and with your history of diabetes
Fi seenaa dhibee waa’ee sukkaaraakee waliin
and you know it feels like my chest is like gonna crush
Beektaa, Akka Waan lapheenkoo caccabaa jiruutti natti dhaga’amaam
and you know people cough on me all the time
Akka namni yeroo hundaa natti qufa’ammoo beekta.
and you're having chest pain
Fi laphee dhukkubbiis qabaachaa jirta
and your symptoms do not go away in five days
Fi mallattooleenkee kun guyyaa shan keessatti sin hin badu
and you said this is a pressure in your chest
Akka ati jettetti kuni dhiibbaa lapheekee keessaati.
anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure
Matiikee keessaa dhibee onnee, koolestroolii olka’aa fi dhiibbaa dhiigaa namni qabu jiraa?
any other symptoms or problems that you notice with the muscle aches?
Mallattoo ykn rakkinni biroon ati dhibee maashaa waliin dubbattu jiraa?
any sharp pain on your left side of your chest?
Lapheekee karaa bitaa irra dhukkubbii cimaa sitti dhaga’amu jiraa?
are there other people sick as you at home with your same symptoms?
Mallattoo walfakkaataadhaan mana keessatti akkakee kan dhukkubsatan jiruu?
are you having any difficulty breathing now
Rakkina afuura baafachuu kamiyyuu amma qabdaa?
are you having any other symptoms?
Mallattoo kan biraa qabdaa?
are you having any shortness of breath?
Hafuurrikee ciccitaa jiraa?
are you still having the chest pain
ha’a lapheekoorraa nawaraanaa jira
because this is flu season
Sababni isaa yeroon kun wayita (flu)ti.
besides the diabetes do you have other problems or important diseases?
Dhibee sukkaaraa malee rakkina kan bira yookiin dhibee baramaa qabdaa?
but also we shouldn't be put aside for the heart cardiac origin chest pain
Garuu Dhibee onnee irraa kan ka’u dhukkubbii laphee waliin walbira kaa’uu hin qabnu.
but a more important problem now is this chest pain
Garuu wanti amma caalaa fayyadu dhukkuba qomaa kanadha.
but if you have the cough
Garuu qufaa yoo qabaatte
but i have difficulty breathing
Garuu an dhibee hargansuu cimaan qaba
but i know lot of people cough on me
Garuu an namoota baay’ee natti jedhanii qufa’an nan beeka
but we need to treat every chest pain with the utmost seriousness
Garuu namoota dhibee laphee qaban kamiyyuu xiyyeeffannoodhaan yaaluu qabna.
but you're breathing all right right now right?
Garuu yeroo ammaa haala gaariin afuura baafachaa jirtaa?
'cause of this chest pain i totally forgot
Sababa dhukkubbii lapheef jedhee nan irraanfadhe
'cause they're having a cough
Sababni isaas qufaa qabaachaa jiru
does it feel like somebody squeezing your chest
Akka waan namni qomakee qubaan tuttuquutti sitti dhaga’amaa?
do still feel like shortness of breath
Ammayyuu miirri afuura si kutuu sitti dhaga’amaa?
do they complain of being sick similar symptoms?
Malllattoo walfakkaataan dhibamuu isanii himataniiruu?
do you have any blood pressure problem as far as you know?
Hamma beektutti dhukkuba dhiibbaa dhiigaa ni qabdaa?
do you have any other chronic like high blood pressure or anything like that?
Dhibeewwan ciccimoo biroo kan akka dhiibbaa dhiigaafi kana fakkaatan qabdaa?
do you have any other diseases chronic medical problems like diabetes?
Dhibee biroo kan akka sukkaaraa irraa hin fayyamne qabdaa?
do you have any shortness of breath with that chest pain?
Dhukkubbii laphee sana duukaa mallattoo afuura kutuu kamuu qabdaa?
do you have high blood pressure?
Dhiibbaa dhiigaa qabdaa?
do you have some shortness of breath goes with that?
Sanaa wajjin kan wal-qabatu afuura si kutaa?
do you know what symptoms she was having?
Mallattoowwan akkamii agarsiisaa akka isheen jirtu beektaa?
do your relatives have the same symptoms
Namoota itti siqtu keessaa mallattoo wal-fakkaataa kan qaban jiruu?
do you see the image?
Suuricha ilaalteettaa?
drink plenty of fluids today
Har’a dhangala’aa sirriitti dhugi
have a dry cough a cold and runny nose vomiting diarrhea
Qufaa gogaa, furrii qal’aa fi qorra, ol-deebisuu, garaa kaasaa qabdaa?
however i take tests for the diabetes
ta’ullee dhibee sukkaaraatif qoranoowwan taasiseera.
however she has symptoms quite similar to mine
Haata’u malee isheen mallattoo kankoo waliin wal fakkaatu qabdi.
how high is your fever?
Ho’inni qaamaakee hangam ol ka’aadha?
how' s your blood pressure?
Dhiibbaan dhiigaakee akkam?
i don't think i have high blood pressure
Dhiibbaa dhiigaa qaba jedhee hin yaadu
i feel a pain in the chest here in the front part of the chest
Lapheekoo irra dhukkubbiin natti dhaga’ama, as qomakoo bira
if you continue to have high fevers
Yoo ol ka’iinsi Ho’ina qaamakee itti fufa ta’e
if you have a fever of a hundred and two or higher
Yoo ati hoo’ina qaamaa dhibba fi lama yookaan immoo isaa ol qabda ta’e
if you think that your symptoms or problems warrant a better look
Mallattoowwaniifi rakkoowwankee fooyya’aa jira jettee yaadda yoo ta’e
i got a fever yesterday
Kaleessa ho’inni qaamaa na qabe
i got a slight fever too
Ho’ina qaamaa xiqqoon qaba
i had a fever yesterday
Ho’inni qaamaa kaleessa na qabate
i had a short sharp pain in my chest
Lapheekoo na waraana
i have a sharp pain here in the chest
Waraansa lapheen qaba
i have hay fever though too
Akkasumas ho’ina qaamaa guddaan qaba
i have made on the body around the chest area?
Qaama keessaa Nannoo laphee irrattin hojjedhe
i have some difficulty breathing too
Rakkina afuura baafachuu xinnoo qaba
i'll send you an image
Suuraa sifan erga.
i'm having some chest pain today
waraansi laphee sun amallee sitti dhagahamaa
i'm just having some headaches and some fever today
Har’a sirriitti mataa bowuu fi ho’ina qaamaatu natti dhaga’amaa jira.
in my opinion it is flu
Akkan yaadutti fludha.
in my opinion this is a little flu
Akkan yaadutti kun flu xinnoodha
i see it going from the center of your chest going up to your neck
Utuunni qomakee irraa gara mormakeetti deemuu nan arga.
is it like some heavy heavy person sitting on your chest?
Akka waan namni baay’ee ulfaataan qomakeerra taa’aa jiruu sitti fakkaataa?
it all started with the headaches and with the fever about the same time
Kun hundi mataa bowuu fi ho’ina qaamaa waliin yeroo wal fakkaataa jalqabe
it hurts in the chest
Laphee keessa na huba
it hurts in the middle of my chest
Wiirtuu lapheekootii baayyee na hubeera
it is a pressure like chest pain
Dhukkubbii laphee dhiibbaa fakkaatuudha
it is in my chest
Lapheekoo keessadha
it is in the center of my chest
Wiirtuu lapheekotii keessa jira
it is in the center of the chest
Inni wiirtuu laphee keessa
it is occurring right in the middle of my chest
Wiirtuu lapheekoo keessatti ta’aa jira
it is right in the center of my chest
Keessa wiirtuu lapheekootiiti
it sounds like you just may have the garden variety cold or a flu
waan ati qabaana gordubaa garagaraa yookiin qufa qabaachuu waan dandeechu fakkaata.
i've got pain in my chest
Lapheekoo keessatti dhukkubbiitu natti dhaga’ame
i've very concerned of this chest pain
Dhukkubbii lapheekoo kanatu baayyee na miidhaa jira.
i want you to tell me in describing this chest pain
Ibsa dhibee laphee kanaa akkati natti himtun barbaada.
i will send you an image
Suuraa siifan erga
i will send you an image on your screen
Bilbilakee irratti suuraa siifan erga
like high blood pressure or diabetes
Waan akka dhiibbaa dhiigaa yookaan dhibee sukkaaraa
like right in the center of the chest
Wiirtuu lapheekoo natti fakkaata
most of the time it is this type of chest pain
Yeroo baayyee gosa dhibee lapheeti.
my sister has similar symptoms
Obboleettiinkoos mallattoo wal fakkaataa qabdi
now for the fever you can take a tachipirina sweet
Amma ho’ina qaamaaf mi’ooftuuwwan akka tachipirina fudhachuu dandeessa
now i send you an image
Amma suuraa siifan erga
now mary how many days have you had the symptoms
Mary erga mallattooleen sirratti mul’achuutti jalqabee guyyaa meeqa ta’eera?
now you said you have a chest pain
Amma lapheekootu na dhukkuba jette
occasionally i have some chest pain
Darbe darbee dhukkubbii laphee hamma ta’e qaba
okay are you having any other symptoms along with this other than just the pain
Tole dhukkubbii malee Mallattooleen biraa waanti sitti dhaga’amaa jiru jiraa?
or if you have high blood pressure
Ykn yoo dhiibbaa dhiigaa guddaa qabaatte
or somebody sitting on your chest?
Ykn namni biroon qomakeerra waan taa’aa jiru sitti fakkaataa?
pretty much the same with the fever and the cough headache and muscle pains
Baayyee ho’ina qaamaa, qufaa, mataa dhukkubbii fi dhukkubbii maashaalee waliin wal fakkaata.
right in the middle of my chest
Wiirtuu lapheekootii keessa jira
show me on this image where you feel the pain
Suuraa kanarratti dhukkubichi eessatti akka sitti hammaate natti agarsiisi.
since you have a fever
Yeroo ho’ina qaamaa qabaachaa turte
so do you think that some of these symptoms could be related to being pregnant?
Kanaafuu mallattooleen kun ulfaa’uu waliin wal-qabata jettee yaaddaa?
so your chest pain started this morning
Kanaaf dhukkubbiin qomaakee ganama kana jalqabee?
so your children are having some of the same symptoms?
Kaanaafuu, ijoolleenkees mallattoo wal-fakkaataa qabachaa jiruu?
tell me about your chest pain
Waa’ee dhukkubbii lapheekee natti himi.
the fever increases at night
Ho’inni qaamaa galgala galgalaa dabala
the fever i've had for the last two days
Hoi’inni qaamaa Guyyaa lamaan darban kaasee narra ture
the fever started to increase last night
Ho’inni qaamaa galgala darbe ol ka’uu jalqabe
the fever started two days ago
Ho’inni qaamaa guyyaa lama dura jalqabe
the muscle pains with the hay fever
Dhukkubbii maashaa olka’iinsaa qaamaa waliin
this is doctor porter in the emergency room triage center
Kun doctor Porter kan kutaa yaalii ariifachiisaa keessa hojjetuudha
well can you tell me a little bit more about your chest pain?
Gaariidha. Xinnoo waa’ee dhukkubbii laphee keetii kana caalmatti natti himuu ni dandeessaa?
well from my point of view it is a little flu
Gaariidha, akkan ilaalutti flu xinnoodha
well i feel a pain in the front of my body here in my chest
As qaamakoo fuulduraa keessatti lapheekoo keessaa dhikkubbiin natti dhaga’ama
well i've been having a strong pain in my chest
Gaariiidha, anaan qomakoorra baay’ee na dhukkubaa jira.
well madam from listening to your symptoms it sounds like you've got one of the flu viruses
Tole maadaam akkan mallattooleekee dhaggeeffadhetti gosoota vayirasii flu keessaa tokko waan si qabe fakkaata.
well when i have that pain in my chest
Gaariidha,yeroo dkukkubii laphee sana qabuudha
what kinda pain do you have in your chest?
Laphee kee keessaa dhukkubbii gosa akkamiitu sitti dhaga’ama?
when this chest pain started?
Dhukkubbiin laphee kun yoom si jalqabe?
where do you have the pain in the chest?
Qomakee keessaa garam si dhukkuba?
where you feel this chest pain eel this chest t
Miirri dhukkubbii qomakeetii garamiin sitti dhaga’ama?
you are probably having chest pain
Ati dhibee laphee qabaachaa jirta fakkaata
you feel like tightness on your chest
Miirri dhippachuu lapheekee irraa sitti dhaga’amaa
you know i got diabetes and stuff
Dhukkubni sukkaaraa akka na qabe beekta
you said you're having this chest pain
Dhukkubbii laphee kana qaba naan jetteetta.
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
Gamtaa Awurooppaa/ Naannoo Diinagdee Awurooppaa fi yuunaayitid kiingidam keessatti ida’amni vaayirasii koroonaa (COVID-19) saffisaan dabaluun amajjii 1 hanga Bitootessa 15, 2020tti.
The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries.
Taateen waliigala dhukkuba vaayirasii koroonaa (COVID-19) biyyoota Gamtaa Awurooppaa/ Naannawa Diinagdee Awurooppaa fi Yuunaayitid Kiingidam adeemsa walfakkaataa agarsiisaa jiru, sadarkaa garagaraatti biyyoota irratti kan hundaa’u ta’us, COVID-19 biyyoota hundatti saffisaan dabalaa jira.
Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care.
Muuxannoo Itaalii irraa argame irratti hundaa’uun, biyyoonnii, hospitaalonnii fi jiddugalli yaala fayyaa addaa qophaa’ummaa isaanii ol guddisuun dhukkubsattoota COVID-19 yaala barbaadaniif, fi addatti kanneen yaala addaa barbaadaniif ooluu qabu.
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China.
Muddee 31, 2019 irratti, dhukkubsataa gosa niimooniyaa qorannoon hin beekamne Wuhaan, kutaa Hubei, Chaayinaa irraa gabaafame.
On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Amajjii 9, 2020, Giddugalli Ittisaa fi Too’annoo Fayyaa Chaayinaa akka gabaasetti qaamni vaayirasii haaraa koroonaa fidu amma akka severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)’tti ibsama.
Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19).
Ergasii, dhukkubni SARS-CoV-2’n hubamuu irraa dhufu dhukkuba vaayirasii koroonaa (COVID-19) jedhamee moggaafame.
Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover.
Akka ragaan yerootti qaamota COVID-19 qabaman keessaa 80% dhibee salphaa qabaatu, kana jechuun, dhukkubsachuun qaama hargansuu niimooniyaa qabaatus dhabaatus,hedduun isaanii ni dandamatu.
In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care.
Dhimmoota ca 14% keessatti, COVID-19 gara dhukkuba daran hammaataa kan hospitaala seensisuu barbaadutti dagaaga dhimmooti 6% hafan immoo dhukkuba jabaa kunuunsa cimaa barbaadan keessummeessu.
The mortality of patients hospitalised due to COVID-19 is ca 4%.
Hammi du’aa dhukkubsattoota sababa COVID-19 hospitaala galanii ca 4% dha.
In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China.
Qorannoo kana keessatti, taatee waliigala COVID-19 kan biyyoota (EU/EEA) fi (UK) qoranneeti kan Chaayinaa, kutaa Hubii wajjiin walmadaalchifne.
We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020.
Ammas dhukkubsattoota COVID-19 EU/EEA fi UK isa Itaalii gaafa amajjii 31- bitootessa 15, 2020 wajjiin wal madaalchifna.
COVID-19 cases in EU/EEA countries and the UK
Dhimmoota COVID-19 biyyoota EU/EEA fi UK keessatti
Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country.
Chaayinaatti aanee, COVID-19 faffaca’insa ji’oogiraafikaawaa caalaa adeemsiseera akkasumas humni cimaa weerara COVID-19 biyyoota addunyaa hafanii yeroo ammaa kan biyya kanaa hordofa.
On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic.
Bitootessa 11, 2020tti hogganaa olaanaan dhaabbata fayyaa addunyaa (WHO) COVID-19’n weerara addunyaa ta’uu labse.
In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition.
Bitootessa 5 keessa dhimmi yuuroosarveelaansii 2020, ispiiter iit aal. Akkaataa hiikaa dhukkubsataa Dhaabbata Fayyaa Addunyaatti dhukkubsataan COVID-19 jalqabaa Awurooppaa gabaafame.
In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China.
EU/EEA keessatti, dhimmoonni mirkanaa’an sadan jalqabaa Amajji 24, 2020 tti namoota Wuhaan, Konyaawwan Hubei, Chaayinaatii deebi’an keessatti Faransaayiin gabaafaman.
As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone.
Akka Bitootessa 15, 2020 tti, dhimmootni COVID-19 biyyoota EU/EEA 30’n hundumaa fi UK keessatti adda baafamaniiru, Mudde 31, 2019 fi guyyaa sana dabalatee gidduu, dhimmoota 39,768 fi du’a 1,727 gabaafamaniiru, Xaaliyaan qofaa irraa dhimmoota 17,750 fi du’a 1,441 waliin.
Obtaining cumulative number and cumulative incidence of COVID-19 cases
Ida’ama lakkoofsaa fi ida’ama taatee dhukkubsattoota COVID-19 fudhataa jira
At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m.
Jiddugala Ittisaa fi Too’annoo Dhibee Awurooppaa (ECDC)’tti, dhukkubsattoonni COVID-19 guutuu addunyaatti lakkaa’aman, kan madda seera qabeessa kanneen akka ‘ Ministeera Fayyaa, abbootii taayitaa fayyaa naannoo fi biyyaa akkasumas Dhaabbata Fayyaa Addunyaa (WHO), guyyaa hunda sa’aatii 8:00 a.m’tti ibsama.
These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy.
Odeeffannoo kun adeemsa COVID-19 EU/EEA fi UK tilmaamuuf oole, fi sanas Itaalii wajjiin walmadaalchisuuf.
As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period.
Walfakkeenya dhukkubsattoota COVID-19’tti, waliigala dhukkubsattoota COVID-19 guyyaa-14 gabaabbate herreegne, kanaafuu madda uumamaa COVID-19 yaada keessa galchuun, tokkoo tokkoo biyyoota EU/EEA fi UK, yerooo amajjii 1–bitootessa 15, 2020 .
We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period.
Akka bitootessa 15, 2020 8:00 a.m. itti ida’ama lakkoofsa dhukkubsattoota adda bahanii kan Itaalii yeroo amajjii 31- bitootessa 15, 2020tiin wal bira qabuun dhiheessine.
Trends of COVID-19 in EU/EEA countries and the UK
Kallattiiwwan waliigalaa COVID-19 biyyoota EU/EEA fi UK keessatti
The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1).
Adeemsi guyyaa 14 taatee waliigala dhukkubsattoota COVID-19 biyyoota EU/EEA fi UK gabaabse waliigalatti kan (Chaayinaa) kutaa Hubei hordofeeti (fakkii 1).
For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material).
EU/EEA fi UK waliigalaatiif, ida’amni taatee COVID-19 Gurraandhala 21 dabaluu eegale fi Gurraandhala 28, 2020 hedduu dabale (meeshaa dabalataa).
This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material).
Kun hundi baay’ina dhukkubsataa Itaaliitti saffisaan dabalaa jiruutiin oofama, garuu biyyoonni EU/EEA fi UK dabalatee taateewwan COVID-19 bifa walfakkaataan dabalaa jiru (Meeshaa dabalataa).
Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period.
Fakkiin 2 ida’ama lakkoofsa dhukkubsattoota COVID-19 kan biyyoota EU/EEA fi UK isa Itaalii wajjiin wal bira qabame kan yeroo amajjii 31 - bitootessa 15, 2020 agarsiisa.
It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less.
Akka ibsa bitootessa 15 8:00 a.m. itti, biyyoonni biro EU/EEA 15 fi UK baay’ina dhukkubsattoota Itaalidhaan walmadaalu yeroo torban 3 hin hanqanne keessatti gabaase.
Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK.
Akka ragaan keenya agarsiisutti baay’inni dhukkubsattoota COVID-19 EU/EEA fi UK’tti saffisaan dabalaa jira.
The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries.
Kallattiiwwan waliigalaa mudannoo COVID-19 suuta dabalaa adeemu keessatti ilaalaman weerarri addunyaawaa saffisa walfakkaataan biyyoota hunda keessatti itti fufaa jiraachuu isaa yaada dhiyeesse.
This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing.
Kun biyyoonni sadarkaa garaagaraa irra jiratanis, garaagarummaan deebii fayyaa hawaasaa biyyaalessaa, fi dhukkubsataadhaaf hiika garaagaraa kennu akkasumas dhukkubsataa COVID-19’f qoratame adda baasuuf adeemsa garagaraa, qorannaa irra keessoos dabalata.
Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity.
Jalqaba bitootessa 2020, doktoroonni Itaalii naannawa faalametti argaman haalicha akka ibsanitti dhukkubsattoota COVID-19 keessaa ca 10% yaala fayyaa addaa barbaadu akkasumas hospitaalonnii fi tajaajiloonni fayyaa addaa akka guutaman maddeen miidiyaa gabaasee jira.
Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown).
Odeeffannoon hospitaala keessatti argamuu dhukkubsataa COVID-19 fi/yookaan yaalli addaa yeroo ammaa kana sadarkaa EU/EEA dhukkubsattoota 6% fi 1% qofa, wal duraa duubaan argama (odeeffannoon hin agarsiifamne).
They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths.
Isaan, ta’us, karaa sirnaawaa ta’een to’annoo deetaa yeroo ammaa kan lakkoofsa dhimmoota gabaafamaniifi lakkoofsa du’aa irratti xiyyeeffatu hawwataa gochuuf sassabamuu qabu.
A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal.
Qorannoon bara 2010–11 gaggeeffame kan mul’ise dhiheessi yaala fayyaa addaa fi yaala fayyaa saffisaa Awurooppaatti garaagarummaa qabaachuu, Jarmanitti namoota 100,000 siree 29.2 hanga 4.2 gidduutti argama.
This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11).
Kana jechuun biyyoonni Itaalii caalaa qabeenya (yaala fayyaa addaa 12.5 fi iddoo ciisicha hatattamaa baay’ina ummataa 100,000’f bara 2010-11) qabaachuu danda’u jechuudha.
Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19.
Barreeffama fakkeenyummaa tasgabbii humna yaala fayyaa wajjiin walitti dhihaatu, tilmaama tokkoo tokkoo biyyoota EU/EEA fi UK’tiif walfakkeenya dhukkubsattoota COVID-19 umrii wajjiin walitti hidhata qaban hospitaala tursiifamaniif; balaan humna siree yaala addaa irra darbuu &gt;90%, kan dhihaate sirreeffama ji’a jahaa ittisa balaa saffisaa COVID-19 irrattii ECDC keessatti.
Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level.
Erga yerooo darbe dhukkubsattoonni biyyoota EU/EEA fi UK’tti naannoo ta’etti walitti qabamanii, akkasumas hospitaalaa fi yaalli fayyaa addaa yeroo hunda ummata naannichaa tajaajila, odeeffannoon waa’ee dhukkubsataa fi yaala addaa qaama daangaarratti istaatiksii 2 (NUTS-2)’tiif moggaafametti argama.
The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK.
Muuxannoon Itaalii irraa argamee fi wanti amma biyyoota biraatti deemaa jiru akka mul’isutti COVID-19 EU/EEA fi UK keessatti saffisaan dabalaa jira.
Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy.
Biyyoonni, hospitaalonni fi iddoon yaala fayyaa addaa dhukkuba SARS-CoV-2 saffisaan daddarbaa jiruuf of qopheessuu qabu akkasumas lakkoofsi namoota COVID-19 dhukkubsatanii dabaluun, fi addatti yaalli addaa, kan akka isa kutaalee Itaalii naannolee Itaaliitti ta’aa jiruu.
As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time.
Akka xiinxala dhiyeenyaa balaa saffisaa ECDC’n agarsiifameetti, itti dhiyeenyi saffisaa, waantonni akka ta’aniif dafee kakaasu akkasumas hunda galeessa ta’e faffaca’insa SARS-COV-2 duubatti hambisuuf barbaachisaadha, gocha waanta hamaa to’achuu irraa gara itti dhiyeenya fooyyessuutti jijjiiruu waliin, akka daballiin saffisaa lakkoofsa dhimmootaa eegamu murtee kennitootaafi hospitaalotaaf akka isaan sirriitti qalbifataniif, fudhataniif akkasumas deebii isaanii haala Kanaan madaqsuuf yoo dursee hojiirra hin oolle ta’e yeroo gahaa kennuu dhiisuu mala.
The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic.
Saffisaan balaa too’achuun miidhaa weerarichaa hir’isuuf madaala fayyaa hawaasaas tartiibessa.
There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare.
Yeroo biyyoonni tatamsa’iinsa SARS-CoV-2 hir’isuudhaaf tattaaffii humna ittisaa isaanii dabalanii fi dhiibbaa yaala fayyaa hir’isanitti fooddaa carraa gabaabduutu jira.
Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks.
Kun kufuun, sirni fayyaa biyyoota EU/EEA dhukkubsattoota yaala addaa barbaadan hedduu guyyoota yookaan torbanoota as deeman keessatti ni keessummeessu.
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans.
Weerarri Coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2)’dhaan dhufu, kana dura namoota 3,000 ajjeese fi Chaayinaatti namoota 80,000 qabee akkasumas addunyaa iddoo hundatti, dhala namaatti balaa cimaa fidaa jira
Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism.
Vaayirasii walfakkaataa isaatiin kan walfakkaatu, SARS-CoV, kan bara 2003 namoota kumaatamaan SARS qabsiise, SARS-CoV-2 simbira halkanii irraa daddarbuu kan danda’uu fi karaa walfakkaataan mallattoo walfakkaataa mul’isuu kan danda’uudha.
However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women.
Ta’us, COVID-19 hammeenyaafi hamma du’aa SARS irra gadi aanaa qaba garuu baay’ee kan daddarbuufi dargaggoo irra maanguddoo akkasumas dubartoota caalaa dhiirota irra dhiibbaa geessisa.
In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject.
Dhukkuba mul’ataa jiru irratti maxxansoota saffisaan lakkoofsaan dabalaa jiraniif deebii kennuuf, barreeffamni kun keeddeebii gosa barnootaa saffisaan dagaagaa jiru yeroonfi hunda galeessa ta’e dhiyeessuuf yaala.
We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease.
Nuti waa’ee epidoomolojii, itiyoolojii, vaayiroolojii, qorannaa mallattoo, yaala, qorannaa dhibee, fi ittisa dhibee irratti wantoota jalqabaa ni haguugna.
Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease.
Gaaffiiwwan baay’een ammayyuu deebiiwwan kan barbaadan ta’anis, keeddeebiin kun hubannaafi dhabamsiisa dhukkuba sodaachisaa hubachuuf ni gargaara jennee abdanna.
The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease.
Feestivaalli arfaasaa amajjii 25, 2020 Chaayinootaaf guyyaa ayyaanaa hunda torbanoota hedduu sababa weerara dhibee vaayirasii haaraatiif manatti dabarsan ayyaana yaadannoo jalqabaa fi hin dagatamne ta’eefi.
The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19).
Vaayirasichi weerrara vaayirasii koroonaa (CoV) kan bara 2003 severe acute respiratory syndrome (SARS) geessise; kanaafuu, SARS-CoV-2 jedhamee dhaabbata fayyaa addunyaatiin gurraandhala 11, 2020 moggaafame, akkasumas dhukkuboonni kanatti dhihaatan CoV Disease-19 (COVID-19) jedhamanii moggaafaman.
The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world.
Weerarichi kan eegale Chaayinaa Wuhaanitti, fi saffisaan guutuu biyyaatti tatamsa’e akkasumas biyyoota addunyaa 50tti dhihaatan keessatti babal’ate.
As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died.
Akka Bitootessa 2, 2020 tti, vaayirasichi dhimmoota COVID-19 mirkanaa’an 80,000 ol keessatti argameera, dhukkubsattoota 40,000 ol kan hospitaalaa fayyanii ba’aniifi dhukkubsattoota 3,000 kan du’an waliin.
WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism.
COVID-19’n “diina ummataa lakk 1” fi shororkeessummaa caala humna qabeessaa akka ta’e Dhaabbanni Fayyaa Addunyaa (WHO) akeekkachiise.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients.
Akka PubMed’tti (https://www.ncbi.nlm.nih.gov/pubmed/)’tti, yeroo ji’oota lama hin caalletti, waraqaawwan 200 ol COVID-19 irratti hojjatame qo’annaa vaayirasii, qo’annaa weeraraa, qorannaa madda dhibee, yaala, fi waldhaansas of keeessatti qabu guyyaa gabaasa jalqabaa amajjii 7, 2020 vaayirasichi dhukkubsattoota heddu irraa adda bahetti irraa eegale gaggeeffame.
This review attempts to summarize the research progress in the new and swiftly developing subject area.
Keeddeebiin kun waan qorannichi irra ga’e gosa barnootaa haaraafi ariitin dagaagaa jiruun goolabuuf yaala.
Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012).
Yeroo danda’ametti, COVID-19 SARS fi dhukkuboota CoV’n dhufan, Middle East respiratory syndrome (weerara MERS bara 2012 keessa ture) wajjiin walmadaalchisuuf ni yaalla
We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions.
Nuyi wantoota hamma ammaatti waan ittisaafi adeemsa dhukkubichaa ilaalchisee baranne akkasumas gaaffiiwwan hafan muraasa garuu barbaachisoo ta’an irratti ni mari’anna.
CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4.
CoVs’n akka aadaatti kan nama ajjeesu akka hin taanetti fudhatama, caalmaatti qufaa 4 kan 15% dhihaatu fida.
However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality.
Ta’us, jaarraa kana keessatti, si’a lama waantoonni dhukkuba fidan CoVwwan kan ilmaan namaa nu quunnamaniiru, sunis, SARS-CoV fi MERS-CoV, kan jalqabbii weeraraa jalqaba Chaayinaa keessa 2003 tti fi Saawud Arabiyaa keessa 2012 tti geessise, walduraa duubaan, akkasumas battaluma biyyoota baay’ee kan biroo keessatti dhukkubaafi du’a rifachiisaa waliin faffaca’e.
Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans.
Kanaafuu, COVID-19’n ammaa kun weerara CoV isa sadaffaa ta’ee seenaa dhala namaa keessatti galmaa’e.
As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission.
Akka Fakkii. Fakkii.1,1keessatti agarsiifameetti, gujjiiwwan michii sombaa madda hin beekamne qaban jalqaba Wuhaan irraa Mudde 31, 2019 tti gara Koomishinii Fayyaa Biyyoolessaa Chaayiinaatti (China National Health Commission) gabaafaman.
Seven days later the sequence of the CoV was released.
Turtii guyyaa torbaa booda adeemsi CoV gad lakkifame.
On January 15, 2020 the first fatal case from Wuhan was reported.
Amajjii 15, 2020 namni jalqaba Wuhaan irraa du’e gabaafame.
Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries.
Hangasitti, weerarichi saffisaan magaalota, konyaawwwaniifi biyyoota ollaatti faffaca’e.
On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible.
Amajji 20 tti, hubamuun dhiyeessitoota kunuunsa fayyaa, daddarbiinsi namaa gara namaatti danda’amuusaa yaada dhiyeessuun gabaafameera.
On January 23, the city of Wuhan was locked down with all its public transportation stopped.
Amajjii 23tti, magaalaan Wuhaan geejjiba ummataas dabalatee cufamte.
On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source.
Amajji 24 tti qu’annoon kilinikaawaa jalqabaa dhukkubicha irrattii, dhukkubsattoota dhimmoota mirkanaa’an waliinii 41 keessaa, 21 qofaatu gabaa qurxummii galaanaa wuhaan kan iddoo jalqabbii dhukkubichaa bineensa maddi isaa hin beekamne irraa jedhamee yaadamu waliin quunnamtii kallattii qabu jechuun gabaase.
On January 30, WHO declared the outbreak a global health emergency.
Amajjii 30tti, dhaabbanni fayyaa addunyaa weeraricha muddama fayyaa addunyaa jedhee labse.
By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2).
Yeroo gabaasa kanaatti, dhukkubichi Chaayinaa fi biyyoota addunyaa 50’tti siqan keessa tatamsa’ee jira (gabatee. ​(gabatee.2).2).
As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined.
Akkuma haalichi saffisaan mul’achaa deemeen, bal’inni xumuraa fi hammeenyi dhibee rifaasisaa kan tilmaamamu ta’a.
On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Gurraandhala 11, 2020 tti, qu’annoon waan-wiirtuu-baay’ee dhukkubsattoota 8,866 irratti dhukkubsattoota COVID-19 mirkanaa’an 4,021 dabalatee ibsa weerarichaa haareffame akka armaan gadiitti dhiyeesseera (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65.
SARS-CoV-2 namoota umrii kamuu kan miidhu ta’us, garuu caalaatti kanneen umrii 30-65 jidduutti argaman huba.
Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10.
Namoota dhukkubichaan qabaman keessaa hanga walakkaa (47.7%) kan ta’an waggaa 50 oli, baay’ee muraasni 20 gadi, akkasumas namoota dhukkubsatan 14 qofatu umrii 10 gadi.
SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000).
SARS-CoV-2 dhiirota (0.31/100,000) dubartoota (0.27/100,000) caala qabe.
COVID-19 expanded in clusters mainly in and around Hubei.
COVID-19 caalmaan garee fi naannoo Hubiitti kan tatamsa’eedha.
COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
COVID-19 erga qoratamuu eegalee booda jiddugaleessaan guyyaa 5 (2-9) fudhate.
The average incubation period was 4.8 (3.0-7.2) days.
Yeroon cal’isaa jiddugaleessaa guyyoota 4.8 (3.0-7.2) ti.
The average time from onset to death was 9.5 (4.8-13) days.
Yeroon jiddugaleessaa qabamuurraa hanga du’aatti jru guyyoota 9.5 (4.8-13) ture.
The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82.
Lakkoofsi hormaataa (R0) bu’uraa ture 3.77 (95% CI: 3.51-4.05), fi R0n sirreeffame immoo 2.23-4.82 ture.
The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China.
Lakkoofsi namoota dhukkubaan qabamanii amajjii 23, 2020 duraa, yeroo imala guddaa ayyaana arfaasaa Chaayinaa wajjiin kan wal simate.
The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%).
Namoota dhukkubsatanii adda baafaman keessaa kanneen du’an 1.44% (95% CI: 1.10-1.86%), fi dhukkubsattoota hunda keessaa kan du’an 3.06% (95% CI: 2.02-4.59%) turan.
Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia.
COVID-19’f haal-dureewwan balaa gurguddoon sadan saala (dhiira), umurii (≥60), akkasumas michii sombaa hammaataadha.
CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA.
CoVwwan damee maatii vaayirasoota gurguddoofi haguuggii qaban kan kajiisa baaqqee kan RNA adda baastuu of keessatti qabataniiti.
They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans.
Isaan jeneeraa afuritti qoodamuu danda’u, sunis, alfaa, beettaa, gaammaa, fi deeltaa, isaan keessaa alfaa- fi beettaa- CoVwwan tu namoota hubuun isaanii beekame.
The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs.
Envelope spike (S) gilaaykoopirootiniin siribduuwwan seelii isaa angiotensin-converting enzyme 2 (ACE2) fi dipeptidyl peptidase 4 (DPP4), SARS-CoV’f fi MERS-CoV’f, walduraa duubaan, waliin walitti hidhata fi isa booda walitti maxxanuun meembireenii uumama.
The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus.
Jiiniin vaayirasii RNA saayitoopilaazimii keessatti kan gadi lakkifamu; jiiniin vaayirasii erga wal baay’ise booda, RNA’n jiinii gilaaykoopirotiinii haguugamaa wajjiin deema akkasumas pirotiiniin niwuukilookaapsiid afuuffee tuuta vaayirasii hamate uumata, booda membireenii pilaazmaa wajjiin walitti baquun vayyirasicha gadi dhiisa.
The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020.
Tartiibni jiinoomii SARS-CoV-2 jalqabaa amajjii 10, 2020 gabaafame.
SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan.
Sumuudota bakka argamaa irraa fudhataman 10 keessaa SARS-CoV-2 adda bahiinsa jeenetikiitii 99.98%’tiin beta-CoV haaraa ta’ee argame. Gabaa Nyaata Galaanaa Huunan Wuhaan keessaa.
SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV.
SARS-CoV-2 SARS-CoV caalaa MERS-CoV’n wal fakkaata.
Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium.
Karaa maaykirooskooppii dabarsa elektirookiitiin qaamonni xixiqqoon SARS-CoV-2 ipiteeliyeemii daandii qilleensa namaa xixiqqoo ta’an keessatti argame.
Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV.
ACE2’n namaa SARS-CoV-2’f akkasumas SARS-CoV’f siribduu ta’uun isaa argameera.
However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV.
Ta’us, pirootiniin S kan SARS-CoV-2 kan SARS-CoV caalaatti haala dadhabaan ACE2 namaa waliin walitti hidhata, kan dhugaa SARS-CoV-2’n SARS-CoV irra dhukkubsattoota keessatti hubamuu hamaa xiqqaa fiduu waliin kan tokko ta’e.
SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8.
SARS-CoV-2 dabalataan pirootinii haaraa gabaabaa orf3b’n haguugame fi pirootinii oomishame orf8’n kan uwwifame hojjechuu danda’a.
The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif.
orf3b SARS-CoV-2 dhukkubbii vaayirasiin dhufuuf ga’ee taphachuu fi mallattoo IFNβ mul’isuu mala; garuu, orf8’n mandhee tajaajilaa beekamu hin qabaatu.
On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1.
Gurraandhala 18, 2020, Zhuu, eet aal., boca cryo-EM ACE2 2.9 Å’tti kan dhala namaa guutuu baattuu amiinoo asidii B0AT1wajjiin walxaxe gabaase.
They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection.
Isaan walxaxichi, caasaalee banamoofi cufamoo kan qabu, akka dimer tti qindaa’ee ture akkasumas walxaxaan ACE2-B0AT1’n pirootinoota S lama walitti hidhuu danda’a, CoV’n adda baasuu fi dhukkubaan hubamuuf kan ragaa dhiyeessu ta’ee argatan.
B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection.
B0AT1 dhukkuba SARS-CoV-2 dhaabuuf kan oolu qoricha calaluuf galma teeraaputiikii ta’uu danda’a.
The origin and intermediate host
Baattoo bu’uuraa fi giddu-deemaa
It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively.
SARS-CoV fi MERS-CoV simbiroota halkanii irraa kan dhufuu fi karaa wal duraa fi duubaan adurree fi gaalaan gara namaatti kan darbu ta’uun beekamaadha.
Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21.
Walbira qaba faayiloojeenik SARS-CoV-2 CoVs biraa wajjiin, simbirri halkanii akka baattoo SARS-CoV-2 hangafaatti akka vaayirasii haaraa 96% CoVs SARS fakkaatuu fi simbira halkanii bat-SL-CoVZX45 fi bat-SL-CoVZX21 jedhamtu irraa fudhatama.
However, what intermediate host helped the virus cross the species barrier to infect humans remains unknown, and the transmission route is yet to be elucidated.
Haa ta’u malee, mandheen yeroo akkamii vaayirasiin sanyii garagaraa keessa jiru akkamitti nama akka qabu isa gargaare osoo hin beekamin hafe, akkasumas karaan daddarba isaa ammas ibsamuu qaba.
Ji, et al., proposed snakes as a carrier of the virus from bats to humans which involved homologous recombination within the S protein.
Ji, et al., bofoota simbirroota halkanii irraa gara namaatti kan S pirootinii keessatti adeemsa kutaaleen DNA cabuun deebia’anii makaawwan alelootaa (alleles) haaraa oomishuuf deebi’anii walitti makaman walfakkaataa ta’e hirmaachise akka baattoo vaayirasichaatti dhiyeesse.
According to a study, researchers in Guangzhou, China, suggested that pangolins - long-snouted, ant-eating mammals often used in traditional Chinese medicine - are the potential intermediate host of SARS-CoV-2 based on 99% genetic homology in a CoV discovered in pangolins and SARS-CoV-2.
Akka qu’annoo tokkootti, qorattoonni Guangzhou, Chaayinaa keessaa, pangoliinonni – huuruu dheeraa, hoosiftoota goondaa-nyaatan kan yeroo baay’ee qoricha aadaa Chaayinootaa keessatti faayidaarra oolan baattoo humna dhokataa giddu galeessaa SARS-CoV-2 akka ta’an homolojii sanyii 99% CoV keessatti Pangoliinotaafi SARS-CoV-2 keessatti argame irratti hundaa’uun yaada dhiyeessan.
However, 1% difference spread all over two genomes is still a big difference; thus, conclusive results for concrete evidence are awaited (Fig. ​(Fig.33).
Haaa ta’u malee, garaagarummaan jiiniiwwan lama jidduutti tatamsa’uu 1% ammas garaagarummaa guddaadha; kanaafuu, bu’aa raga irratti hundaa’etu eeggamaa jira (Fakkii. ​(Fakkii.33).
The physicochemical properties of SARS-CoV-2 are largely not yet known.
Amaloonni fiizikaalaaf keemikaalaa SARS-CoV-2 ammallee baldhinaan hin beekamin jiru.